The BioInsights Podcast
The BioInsights Podcast: discussing the challenges of translating novel biologics from bench to clinic to market.
The BioInsights Podcast
Developing novel radioimmunotherapy combinations for lung cancer treatment
•
BioInsights
•
Season 3
•
Episode 4
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
Lauren Coyle, Commissioning Editor, Immuno-Oncology Insights, speaks to Joe Chang, Clinical Thoracic Oncologist, MD Anderson Cancer Center, University of Texas, who discusses his team’s pioneering work in combining radiation therapy with immunotherapy for lung cancer treatment. He highlights the challenges and promises of optimizing radioimmunotherapy combinations, emphasizing the importance of personalized treatment approaches and collaboration across disciplines to improve patient outcomes.
Can you provide a brief overview of your background and experience in the field of combination radioimmunotherapy, and what sparked your interest in this area?
How do you approach the selection of specific radioimmunotherapy combinations, and what factors do you consider in designing these protocols?
What are the current challenges associated with radioimmunotherapy, considering potential synergies and conflicts between these treatment modalities, and what promises are there to overcome these?
Can you share insights into how combination therapies have impacted patient outcomes in your research?
Collaboration is often essential in research. How do you collaborate with other professionals to enhance the effectiveness of combination therapies?
How do you stay updated on the latest advancements in the field and integrate these into your research?
What are the key goals and priorities for your work in the upcoming years?
Lastly, what is one piece of wisdom you would like to share with the field at large?